The two faces of ACE2: the role of ACE2 receptor and its polymorphisms in hypertension and COVID-19

M Bosso, TA Thanaraj, M Abu-Farha… - … Therapy Methods & …, 2020 - cell.com
The mechanism for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection requires the binding of the virus to the angiotensin-converting enzyme 2 (ACE2) …

Tackling atherosclerosis via selected nutrition

A Vesnina, A Prosekov, V Atuchin, V Minina… - International journal of …, 2022 - mdpi.com
The development and pathogenesis of atherosclerosis are significantly influenced by
lifestyle, particularly nutrition. The modern level of science and technology development …

Genetic hypothesis and pharmacogenetics side of renin-angiotensin-system in COVID-19

D Gemmati, V Tisato - Genes, 2020 - mdpi.com
The importance of host genetics and demography in coronavirus disease 2019 (COVID-19)
is a crucial aspect of infection, prognosis and associated case fatality rate. Individual genetic …

Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases

T Kiiskinen, P Helkkula, K Krebs, J Karjalainen… - Nature medicine, 2023 - nature.com
Little is known about the genetic determinants of medication use in preventing
cardiometabolic diseases. Using the Finnish nationwide drug purchase registry with follow …

Pharmacogenomics of hypertension treatment

J Rysz, B Franczyk, M Rysz-Górzyńska… - International journal of …, 2020 - mdpi.com
Hypertension is one of the strongest modifiable cardiovascular risk factors, affecting an
increasing number of people worldwide. Apart from poor medication adherence, the low …

Sensitive detection of single-nucleotide polymorphisms by conjugated polymers for personalized treatment of hypertension

Q Shen, H Zhang, Y Huang, M Li, H Zhao… - Science Translational …, 2023 - science.org
Genetic variants among individuals have been associated with ineffective control of
hypertension. Previous work has shown that hypertension has a polygenic nature, and …

Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients

SW Chan, TTW Chu, CS Ho, APS Kong… - Frontiers in …, 2021 - frontiersin.org
Purpose: This study was performed to investigate the effects of common polymorphisms in
CYP2D6 and CYP3A5 on the plasma concentrations and antihypertensive effects of …

[HTML][HTML] Personalized antihypertensive treatment guided by pharmacogenomics in China

ZL Xiao, M Yang, XB Chen, XM Xie… - … Diagnosis and Therapy, 2022 - ncbi.nlm.nih.gov
Background The implementation of genotyping for anti-hypertensive drugs in clinical
practice remains a challenge. We conducted this study to analyze the distribution of …

Hypertension in African populations: review and computational insights

SE Mabhida, L Mashatola, M Kaur, JR Sharma… - Genes, 2021 - mdpi.com
Hypertension (HTN) is a persistent public health problem affecting approximately 1.3 billion
individuals globally. Treatment-resistant hypertension (TRH) is defined as high blood …

Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations

SM Altoum, ZN Al-Mahayri, BR Ali - Frontiers in Pharmacology, 2023 - frontiersin.org
Hypertension remains a significant health burden worldwide, re-emphasizing the
outstanding need for more effective and safer antihypertensive therapeutic approaches …